Literature DB >> 20586735

Benign multiple sclerosis: a need for a consensus.

S B Glad1, J H Aarseth, H Nyland, T Riise, K-M Myhr.   

Abstract

OBJECTIVES: To investigate the impact of different definitions on the frequency of benign multiple sclerosis (MS) in patients with a long follow-up, and to study the presence of non-motor symptoms and employment across the definitions.
MATERIALS AND METHODS: All patients alive (n = 188) with disease onset during 1976-1986 in Hordaland County, Norway, were clinically examined including the Expanded Disability Status Scale (EDSS) in 2003. Non-motor symptoms which included depression, cognitive impairment, fatigue and pain, and employment status were also registered. Three definitions of benign MS were used based on the following EDSS cut-off values: 2.0, 3.0 and 4.0. Two additional definitions were added using an EDSS <or=4.0 and incorporating either full-time or full- and part-time employment status.
RESULTS: The frequency of benign MS increased from 14.5% for EDSS <or=2.0 to 40.8% for EDSS <or=4.0, but was only 12.3% for the definition based on full-time employment. Patients with an EDSS <or=2.0 had markedly less non-motor symptoms and lower unemployment rates than the other groups.
CONCLUSIONS: An EDSS score <or=2.0 with at least 10 years of disease duration seems to be the most appropriate criterion in identifying patients with benign MS.

Entities:  

Mesh:

Year:  2010        PMID: 20586735     DOI: 10.1111/j.1600-0404.2010.01375.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  8 in total

Review 1.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

2.  Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.

Authors:  Kristin M Galetta; Jennifer Graves; Lauren S Talman; Deacon J Lile; Elliot M Frohman; Peter A Calabresi; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2012-06       Impact factor: 3.042

Review 3.  Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis.

Authors:  Shahnaz Shahrbanian; Mohammad Auais; Pierre Duquette; Katie Andersen; Katie Anderson; Nancy E Mayo
Journal:  Pain Res Manag       Date:  2013 Sep-Oct       Impact factor: 3.037

4.  Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.

Authors:  Yu Min Huang-Link; Mats Fredrikson; Hans Link
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

5.  Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).

Authors:  Robert Zivadinov; Diane L Cookfair; Lauren Krupp; Aaron E Miller; Neil Lava; Patricia K Coyle; Andrew D Goodman; Burk Jubelt; Michael Lenihan; Joseph Herbert; Malcolm Gottesman; David H Snyder; Brian R Apatoff; Barbara E Teter; Allan B Perel; Frederick Munschauer; Bianca Weinstock-Guttman
Journal:  BMC Neurol       Date:  2016-07-15       Impact factor: 2.474

6.  How common is truly benign MS in a UK population?

Authors:  Emma Clare Tallantyre; Paula C Major; Michael J Atherton; W Adam Davies; Fady Joseph; Valentina Tomassini; Trevor P Pickersgill; Katharine Elizabeth Harding; Mark Douglas Willis; Mia Winter; Neil P Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-09-03       Impact factor: 10.154

7.  Earnings among people with multiple sclerosis compared to references, in total and by educational level and type of occupation: a population-based cohort study at different points in time.

Authors:  Michael Wiberg; Chantelle Murley; Petter Tinghög; Kristina Alexanderson; Edward Palmer; Jan Hillert; Magnus Stenbeck; Emilie Friberg
Journal:  BMJ Open       Date:  2019-07-11       Impact factor: 2.692

8.  Grey matter atrophy in patients with benign multiple sclerosis.

Authors:  Marja Niiranen; Juha Koikkalainen; Jyrki Lötjönen; Tuomas Selander; Antti Cajanus; Päivi Hartikainen; Sakari Simula; Ritva Vanninen; Anne M Remes
Journal:  Brain Behav       Date:  2022-06-28       Impact factor: 3.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.